A research team from Huntsman Cancer Institute at the University of Utah showed a pathway-targeted therapy that could be an effective melanoma treatment.
Related to this article
Faculty convened at an OncLive Scientific Interchange and Workshop to discuss evolving evidence-based decision-making across CSCC.
In case you missed any, check out our recap of the episodes of OncLive On Air that aired in June 2026.
The FDA approved Orca-T, issued a CRL to a NET imaging agent, and more.
Advertisement
Advertisement
Trending on OncLive
1
Dr Ermann on Real-World Data for Zanubrutinib vs Acalabrutinib in Older CLL
2
Subcutaneous Pembrolizumab Faces Scrutiny Over Convenience and Cost for Patients With Cancer
3
Tumor Board: Optimizing NSCLC Care—Leveraging the Latest Evidence on Targeted Therapy and Immuno-Oncology
4
Cutting-Edge Drug Shows Promise for Patients With NRAS-Driven Melanoma
5